Agios Pharmaceuticals

Pharmaceuticals & Biotech

Agios Pharmaceuticals Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Agios Pharmaceuticals?

Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.:Table 1 In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios. In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies. The deal could net more than $1 billion for Agios.

Highest paying job titles at Agios Pharmaceuticals include Senior Scientist, Medical Director, and Director of Biostatistics


Market Cap$2.9 billion
Revenue$80.4 million
5 Year Trend+15.8%
Net Income-$363 million
Annual Report
Total value of jobs:
Total Jobs:
Average Pay:
% Masters:

Agios Pharmaceuticals Salaries

Senior Scientist



Average Salary:$111,250

Medical Director



Average Salary:$138,333

Director of Biostatistics



Average Salary:$181,250

Director Risk Management



Average Salary:$107,143

View All Salaries